The influence of dapagliflozin on cardiac remodeling, myocardial function and metabolomics in type 1 diabetes mellitus rats

BACKGROUND: Sodium-glucose cotransporter (SGLT)2 inhibitors have displayed beneficial effects on the cardiovascular system in diabetes mellitus (DM) patients. As most clinical trials were performed in Type 2 DM, their effects in Type 1 DM have not been established. OBJECTIVE: To evaluate the influen...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Eder Anderson, Rosa, Camila Moreno, Campos, Dijon Henrique Salome, Damatto, Felipe Cesar, Murata, Gilson Masahiro, Souza, Lidiane Moreira, Pagan, Luana Urbano, Gatto, Mariana, Brosler, Jessica Yumi, Souza, Hebreia Oliveira Almeida, Martins, Mario Machado, Bastos, Luciana Machado, Tanni, Suzana Erico, Okoshi, Katashi, Okoshi, Marina Politi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617150/
https://www.ncbi.nlm.nih.gov/pubmed/37908006
http://dx.doi.org/10.1186/s13098-023-01196-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617150/
https://www.ncbi.nlm.nih.gov/pubmed/37908006
http://dx.doi.org/10.1186/s13098-023-01196-6

Ejemplares similares